A detailed history of Geode Capital Management, LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,008,827 shares of AURA stock, worth $8.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,008,827
Previous 969,448 4.06%
Holding current value
$8.41 Million
Previous $7.33 Million 22.64%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.9 - $10.36 $271,715 - $407,966
39,379 Added 4.06%
1,008,827 $8.99 Million
Q2 2024

Aug 09, 2024

BUY
$6.81 - $7.89 $1.28 Million - $1.49 Million
188,258 Added 24.1%
969,448 $7.33 Million
Q1 2024

May 13, 2024

BUY
$7.09 - $9.24 $744,889 - $970,772
105,062 Added 15.54%
781,190 $6.13 Million
Q4 2023

Feb 13, 2024

BUY
$7.02 - $11.98 $1.05 Million - $1.79 Million
149,690 Added 28.43%
676,128 $5.99 Million
Q3 2023

Nov 13, 2023

BUY
$8.97 - $12.38 $240,772 - $332,303
26,842 Added 5.37%
526,438 $4.72 Million
Q2 2023

Aug 11, 2023

BUY
$8.51 - $13.33 $354,764 - $555,701
41,688 Added 9.1%
499,596 $6.17 Million
Q1 2023

May 15, 2023

BUY
$8.88 - $12.11 $1.4 Million - $1.91 Million
157,435 Added 52.4%
457,908 $4.25 Million
Q4 2022

Feb 13, 2023

BUY
$9.86 - $14.59 $110,047 - $162,838
11,161 Added 3.86%
300,473 $3.15 Million
Q3 2022

Nov 14, 2022

BUY
$13.1 - $20.34 $1.07 Million - $1.67 Million
82,018 Added 39.57%
289,312 $5.24 Million
Q2 2022

Aug 12, 2022

BUY
$12.37 - $21.86 $1.26 Million - $2.23 Million
101,960 Added 96.8%
207,294 $2.94 Million
Q1 2022

May 13, 2022

BUY
$15.94 - $23.34 $51,948 - $76,065
3,259 Added 3.19%
105,334 $2.32 Million
Q4 2021

Feb 11, 2022

BUY
$14.76 - $24.89 $1.51 Million - $2.54 Million
102,075 New
102,075 $1.73 Million

Others Institutions Holding AURA

About Aura Biosciences, Inc.


  • Ticker AURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,273,600
  • Market Cap $244M
  • Description
  • Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...
More about AURA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.